From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
The following strategies can help minimise any potential risks
Semaglutide still gets significant search volume and is worth targeting
S.HaoualaF.et al (2023)
In this article, youll learn some of the additional ways that you can benefit from creatine and carnitine, the differences between them, and which is best for you
Our team is dedicated to providing personalized care and support, ensuring that you receive the most effective treatment tailored to your needs
